QVR’s CME Group CME Stock Holding History

QVR’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,000	Closed	-$1.23M	–	316
2022 Q2	$1.23M	Sell	6,000 -8,000	-57%	-$1.7M	0.09%	164
2022 Q1	$3.33M	Buy	+14,000	New	+$3.29M	0.13%	158
2021 Q4	–	Sell	-3,500	Closed	-$677K	–	86
2021 Q3	$677K	Buy	3,500 +1,000	+40%	+$203K	0.04%	231
2021 Q2	$529K	Buy	2,500 +1,500	+150%	+$317K	0.05%	179
2021 Q1	$203K	Buy	+1,000	New	+$197K	0.02%	135

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

QVR's CME Position: Q2 2022 in Review

QVR sold out of CME Group (CME) in Q2 2022, closing a stake of 1,199 shares — an estimated $254K sold.

QVR first reported a position in CME in Q1 2021 and held it in 3 quarters. The position peaked at $285K in Q1 2022. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

QVR reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
QVR sold 1,199 CME Group shares in Q2 2022, an estimated $254K.
QVR first reported a position in CME Group in Q1 2021 and held it in 3 quarters.
QVR's CME Group position peaked at $285K in Q1 2022.
1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on QVR's 13F filing for Q2 2022, filed 1 Aug 2022.